{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:14:46Z","timestamp":1759335286609,"version":"3.41.2"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Keratinocyte carcinoma (KC) treatment accounts for approximately $5 billion in spending per year, yet no studies have evaluated the US general public's willingness to pay (WTP) for these procedures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To determine the monetary value of surgical KC treatments, as perceived by society, as a measure of preference.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PARTICIPANTS, METHODS AND MATERIALS<\/jats:title>\n            <jats:p>We performed an internet-based age-, sex-, and race-stratified cross-sectional survey of 425 subjects representative of the US general population. Stated WTP and desirability of electrodesiccation and curettage (EDC), excision, and Mohs micrographic surgery (MMS) for facial and extrafacial basal cell carcinoma (BCC) were assessed. A discrete choice experiment was performed using maximum likelihood estimation, and a secondary analysis was performed to determine the influence of framing MMS as the best treatment option.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>A total of 425 subjects finished their questionnaires, yielding a completion rate of 97%. Median (interquartile range) stated WTP for EDC, excision, and MMS were $1,000 (421\u20132,079), $1,503 (562\u20133,062), and $3,006 (1,250\u20135,084), respectively, when MMS was framed in a standard fashion. Stated WTP for MMS increased to $3,989 (2,015\u20135,801) when it was framed as the best option. For BCC on the back, WTP for MMS dropped by 12%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>There is markedly higher societal WTP for MMS on both the face and trunk, regardless of whether MMS is framed as the best option. Gold-standard bias may affect WTP and desirability in medical decision-making under uncertainty, inflating the WTP of options framed as the best while decreasing the desirability of alternatives.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002874","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T23:58:38Z","timestamp":1614383918000},"page":"467-472","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Willingness to Pay for Surgical Treatments for Basal Cell Carcinoma: A Population-Based Cross-Sectional Study"],"prefix":"10.1097","volume":"47","author":[{"given":"Jonathan","family":"Kantor","sequence":"first","affiliation":[{"name":"Department of Dermatology, Center for Global Health, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania;"},{"name":"Florida Center for Dermatology, P.A., Saint Augustine, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"e1380","DOI":"10.1097\/GOX.0000000000001380","article-title":"Costs and economics of skin cancer management, Mohs surgery, and surgical reconstruction","volume":"5","author":"Kantor","year":"2017","journal-title":"Plast Reconstr Surg Glob open"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Bichakjian","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamadermatol.2017.0732","article-title":"Mohs micrographic surgery use in the United States based on Medicare data","volume":"153","author":"Kantor","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaad.2008.07.047","article-title":"A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption","volume":"61","author":"Rogers","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/archderm.140.6.736","article-title":"Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis","volume":"140","author":"Bialy","year":"2004","journal-title":"Arch Dermatol"},{"key":"R6-20250731","first-page":"187","article-title":"Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face","volume":"142","author":"Essers","year":"2006","journal-title":"Arch Dermatol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(08)70260-2","article-title":"Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up","volume":"9","author":"Mosterd","year":"2008","journal-title":"Lancet Oncol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archderm.142.9.1235-a","article-title":"Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face","volume":"142","author":"Otley","year":"2006","journal-title":"Arch Dermatol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/DSS.0000000000000756","article-title":"Direct cost-analysis of Mohs micrographic surgery and traditional excision for basal cell carcinoma at initial margin clearance","volume":"42","author":"Sebaratnam","year":"2016","journal-title":"Dermatol Surg"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(04)17399-6","article-title":"Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial","volume":"364","author":"Smeets","year":"2004","journal-title":"Lancet"},{"key":"R11-20250731","first-page":"914","article-title":"Cost effectiveness of Mohs micrographic surgery: review of the literature","volume":"8","author":"Tierney","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","article-title":"AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American academy of dermatology, American college of Mohs surgery, American society for dermatologic surgery association, and the American society for Mohs surgery","volume":"67","author":"Ad Hoc Task","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jamafacial.2018.1526","article-title":"Assessment of casual observers' willingness to pay for increased attractiveness through rhinoplasty","volume":"21","author":"Chen","year":"2019","journal-title":"JAMA Facial Plast Surg"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/j.1524-4725.2010.01805.x","article-title":"Assessing the public's preference for surgical treatment of primary basal cell carcinoma: a discrete-choice experiment in the south of The Netherlands","volume":"36","author":"Essers","year":"2010","journal-title":"Dermatol Surg"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaad.2019.01.080","article-title":"Determining patient preferences and willingness to pay related to scar length and appearance after skin cancer treatment on the face and trunk: a multicenter discrete choice experiment","volume":"81","author":"Golda","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.det.2011.12.002","article-title":"Preference-based measures in dermatology: an overview of utilities and willingness to pay","volume":"30","author":"Seidler","year":"2012","journal-title":"Dermatol Clin"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/jep.13095","article-title":"Estimating willingness-to-pay for health care: a discrete choice experiment accounting for non-attendance to the cost attribute","volume":"25","author":"Sever","year":"2019","journal-title":"J Eval Clin Pract"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/DSS.0000000000001564","article-title":"Patient preferences for the treatment of basal cell carcinoma: a mapping review of discrete choice experiments","volume":"44","author":"Neal","year":"2018","journal-title":"Dermatol Surg"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2340\/00015555-2273","article-title":"Patient preferences for treatment of basal cell carcinoma: importance of cure and cosmetic outcome","volume":"96","author":"Martin","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-5945-12-19","article-title":"What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial","volume":"12","author":"Tinelli","year":"2012","journal-title":"Bmc Dermatol"},{"key":"R21-20250731","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1472-6963-11-85","article-title":"Balancing influence between actors in healthcare decision making (Debate)","volume":"11","author":"Kaplan","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12913-018-3137-3","article-title":"Rationing cancer treatment: a qualitative study of perceptions of legitimate limit-setting","volume":"18","author":"Feiring","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12913-015-1210-8","article-title":"Does it matter whose opinion we seek regarding the allocation of healthcare resources?\u2014a case study","volume":"15","author":"Kolasa","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fmed.2020.00384","article-title":"Non-pharmaceutical interventions for pandemic COVID-19: a cross-sectional investigation of US general public beliefs, attitudes, and actions","volume":"7","author":"Kantor","year":"2020","journal-title":"Front Med"},{"key":"R26-20250731","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jamadermatol.2020.0039","article-title":"What is Mohs surgery?","volume":"156","author":"Etzkorn","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R27-20250731","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","article-title":"Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10year follow-up","volume":"50","author":"van Loo","year":"2014","journal-title":"Eur J Cancer"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1111\/j.1524-4733.2009.00632.x","article-title":"Valuation of the economic benefits of human papillomavirus vaccine in Taiwan","volume":"12","author":"Liao","year":"2009","journal-title":"Value in Health"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1011128332243","article-title":"Contingent valuation: controversies and evidence","volume":"19","author":"Carson","year":"2001","journal-title":"J Eur Assoc Environ Res Econ"},{"key":"R31-20250731","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/bjd.15782","article-title":"Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment","volume":"178","author":"Essers","year":"2018","journal-title":"Br J Dermatol"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/11532240-000000000-00000","article-title":"Does the inclusion of a cost attribute result in different preferences for the surgical treatment of primary basal cell carcinoma?: a comparison of two discrete-choice experiments","volume":"28","author":"Essers","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"R33-20250731","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2165\/00019053-200422180-00004","article-title":"Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma","volume":"22","author":"Weston","year":"2004","journal-title":"PharmacoEconomics"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1369-7625.2010.00646.x","article-title":"The economics of choice: lessons from the U.S. health-care market (Report)","volume":"14","author":"Hanoch","year":"2010","journal-title":"Health Expect"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1369-7625.2010.00658.x","article-title":"Do physicians' recommendations pull patients away from their preferred treatment options? (Report)","volume":"15","author":"Mendel","year":"2012","journal-title":"Health Expect"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"e0197780","DOI":"10.1371\/journal.pone.0197780","article-title":"Willingness to pay for a cure of low-risk melanoma patients in Germany","volume":"13","author":"Augustin","year":"2018","journal-title":"PLoS One"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2307\/3147170","article-title":"Modeling response incentive effects in dichotomous choice contingent valuation data","volume":"73","author":"Alberini","year":"1997","journal-title":"Land Econ"},{"key":"R41-20250731","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/DSS.0000000000001502","article-title":"Skin and soft Tissue surgery in the office versus operating room setting: an analysis based on individual-level Medicare data","volume":"44","author":"Kantor","year":"2018","journal-title":"Dermatol Surg"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamadermatol.2018.4572","article-title":"Mohs appropriate use criteria for superficial basal cell carcinoma","volume":"155","author":"Kantor","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/DSS.0000000000001935","article-title":"Surgical volume of dermatologists who do not perform Mohs micrographic dermatologic surgery: a cross-sectional individual-level analysis using Medicare data","volume":"46","author":"Kantor","year":"2020","journal-title":"Dermatol Surg"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/COC.0000000000000517","article-title":"Mohs micrographic surgery volume, utilization, and overutilization based on Medicare data","volume":"42","author":"Kantor","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"R45-20250731","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/hec.742","article-title":"Conjoint analysis. The cost variable: an Achilles' heel?","volume":"12","author":"Slothuus Skjoldborg","year":"2003","journal-title":"Health Econ"},{"key":"R46-20250731","doi-asserted-by":"crossref","first-page":"e0154078","DOI":"10.1371\/journal.pone.0154078","article-title":"Validity of willingness to pay measures under preference uncertainty","volume":"11","author":"Braun","year":"2016","journal-title":"PLoS One"},{"key":"R47-20250731","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1365-2133.2009.09425.x","article-title":"A comparative study of the effects of disposable and Volkmann spoon curettes in the treatment of basal cell carcinoma","volume":"161","author":"Julian","year":"2009","journal-title":"Br J Dermatol"},{"key":"R48-20250731","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4725.1989.tb03166.x","article-title":"Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"key":"R49-20250731","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1524-4725.1991.tb03425.x","article-title":"Recurrence rates of treated basal cell carcinomas: Part 2: curettage-electrodesiccation","volume":"17","author":"Silverman","year":"1991","journal-title":"J Dermatol Surg Oncol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:12:49Z","timestamp":1753999969000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002874","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"type":"print","value":"1076-0512"},{"type":"electronic","value":"1524-4725"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}